标题
The Oncolytic Virus in Cancer Diagnosis and Treatment
作者
关键词
-
出版物
Frontiers in Oncology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-09-09
DOI
10.3389/fonc.2020.01786
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade
- (2020) Shinsuke Nakao et al. Science Translational Medicine
- Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy
- (2020) Hong-My Nguyen et al. Cells
- Enhancing therapeutic efficacy of oncolytic vaccinia virus armed with Beclin-1, an autophagic Gene in leukemia and myeloma
- (2020) Wen Lei et al. BIOMEDICINE & PHARMACOTHERAPY
- An Oncolytic Vaccinia Virus Armed with GM-CSF and IL-24 Double Genes for Cancer Targeted Therapy
- (2020) Lili Deng et al. OncoTargets and Therapy
- An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses
- (2020) Guan Wang et al. Nature Communications
- Novel Oncolytic Virus Armed with Cancer Suicide Gene and Normal Vasculogenic Gene for Improved Anti-Tumor Activity
- (2020) Su-Nam Jeong et al. Cancers
- Blood Outgrowth Endothelial Cells as a Cellular Carrier for Oncolytic Vesicular Stomatitis Virus Expressing Interferon-β in Preclinical Models of Non-Small Cell Lung Cancer
- (2020) Manish R. Patel et al. Translational Oncology
- Systemic administration of human mesenchymal stromal cells infected with polymer-coated oncolytic adenovirus induces efficient pancreatic tumor homing and infiltration
- (2019) Youjin Na et al. JOURNAL OF CONTROLLED RELEASE
- Designer nanocarriers for navigating the systemic delivery of oncolytic viruses
- (2019) Faith Howard et al. Nanomedicine
- Oncorine, the World First Oncolytic Virus Medicine and its Update in China
- (2018) Min Liang CURRENT CANCER DRUG TARGETS
- Cancer terminator viruses (CTV ): A better solution for viral-based therapy of cancer
- (2018) Luni Emdad et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
- (2018) Frederick F. Lang et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma
- (2018) Jason Chesney et al. JOURNAL OF CLINICAL ONCOLOGY
- Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies
- (2018) Shashi Gujar et al. TRENDS IN IMMUNOLOGY
- A Retroviral Replicating Vector Encoding Cytosine Deaminase and 5-FC Induces Immune Memory in Metastatic Colorectal Cancer Models
- (2018) Kader Yagiz et al. Molecular Therapy-Oncolytics
- Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy
- (2018) Carole Achard et al. EBioMedicine
- PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
- (2018) Dmitriy Zamarin et al. JOURNAL OF CLINICAL INVESTIGATION
- Designing and building oncolytic viruses
- (2017) Justin Maroun et al. Future Virology
- An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results
- (2017) Vignesh T. Packiam et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials
- (2017) Ibrahim Ragab Eissa et al. Frontiers in Oncology
- Long-term treatment with the oncolytic ECHO-7 virus Rigvir of a melanoma stage IV M1c patient, a small cell lung cancer stage IIIA patient, and a histiocytic sarcoma stage IV patient-three case reports
- (2016) Pēteris Alberts et al. APMIS
- Oncolytic viruses: finally delivering
- (2016) Leonard W Seymour et al. BRITISH JOURNAL OF CANCER
- Interview with Robert Coffin, inventor of T-VEC: the first oncolytic immunotherapy approved for the treatment of cancer
- (2016) Robert Coffin Immunotherapy
- Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model
- (2016) Lukasz Kuryk et al. INTERNATIONAL JOURNAL OF CANCER
- Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses
- (2016) Karishma Rajani et al. MOLECULAR THERAPY
- Toca 511 plus 5-fluorocytosine in combination with lomustine shows chemotoxic and immunotherapeutic activity with no additive toxicity in rodent glioblastoma models
- (2016) Kader Yagiz et al. NEURO-ONCOLOGY
- Components of Adenovirus Genome Packaging
- (2016) Yadvinder S. Ahi et al. Frontiers in Microbiology
- Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?
- (2016) E. Pure et al. Cancer Immunology Research
- Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy
- (2016) Hasan Rehman et al. Journal for ImmunoTherapy of Cancer
- Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy
- (2015) J. J. Rojas et al. CLINICAL CANCER RESEARCH
- The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma
- (2015) N. Martinez-Velez et al. CLINICAL CANCER RESEARCH
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective study
- (2015) Simona Doniņa et al. MELANOMA RESEARCH
- Phase 1b Trial of Biweekly Intravenous Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus in Colorectal Cancer
- (2015) Se Hoon Park et al. MOLECULAR THERAPY
- Complement Inhibition Prevents Oncolytic Vaccinia Virus Neutralization in Immune Humans and Cynomolgus Macaques
- (2015) Laura Evgin et al. MOLECULAR THERAPY
- Oncolytic viruses get a boost with first FDA-approval recommendation
- (2015) Elie Dolgin NATURE REVIEWS DRUG DISCOVERY
- Oncolytic viruses: a new class of immunotherapy drugs
- (2015) Howard L. Kaufman et al. NATURE REVIEWS DRUG DISCOVERY
- Going viral: a review of replication-selective oncolytic adenoviruses
- (2015) Christopher Larson et al. Oncotarget
- Doxycycline Inducible Melanogenic Vaccinia Virus as Theranostic Anti-Cancer Agent
- (2015) Lorenz Kirscher et al. Theranostics
- Double-faceted mechanism of parvoviral oncosuppression
- (2015) Karsten Geletneky et al. Current Opinion in Virology
- Oncolytic adenovirus research evolution: from cell-cycle checkpoints to immune checkpoints
- (2015) Hong Jiang et al. Current Opinion in Virology
- Molecular Imaging with Bioluminescence and PET Reveals Viral Oncolysis Kinetics and Tumor Viability
- (2014) D. Kuruppu et al. CANCER RESEARCH
- Oncolytic Measles Virus Expressing the Sodium Iodide Symporter to Treat Drug-Resistant Ovarian Cancer
- (2014) E. Galanis et al. CANCER RESEARCH
- A novel oncolytic viral therapy and imaging technique for gastric cancer using a genetically engineered vaccinia virus carrying the human sodium iodide symporter
- (2014) Kyong-Hwa Jun et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Reovirus Activates Human Dendritic Cells to Promote Innate Antitumor Immunity
- (2014) Fiona Errington et al. JOURNAL OF IMMUNOLOGY
- CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy
- (2014) Christine E Engeland et al. MOLECULAR THERAPY
- A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses
- (2014) James M Markert et al. MOLECULAR THERAPY
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Healing after death: antitumor immunity induced by oncolytic adenoviral therapy
- (2014) Hong Jiang et al. OncoImmunology
- The effects of radiation on antitumor efficacy of an oncolytic adenovirus vector in the Syrian hamster model
- (2013) B A Young et al. CANCER GENE THERAPY
- Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
- (2013) C. J. Breitbach et al. CANCER RESEARCH
- Potential for enhanced therapeutic activity of biological cancer therapies with doxycycline combination
- (2013) H Tang et al. GENE THERAPY
- Combination of fractionated irradiation with anti-VEGF expressing vaccinia virus therapy enhances tumor control by simultaneous radiosensitization of tumor associated endothelium
- (2013) Lisa Buckel et al. INTERNATIONAL JOURNAL OF CANCER
- Seroprevalence of Herpes Simplex Virus Types 1 and 2--United States, 1999-2010
- (2013) H. Bradley et al. JOURNAL OF INFECTIOUS DISEASES
- Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults
- (2013) Shujun Zhang et al. JOURNAL OF MEDICAL VIROLOGY
- Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients
- (2013) Ilkka Liikanen et al. MOLECULAR THERAPY
- Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in V600D/EBRAF mutant melanoma depends on JNK and TNF-α signaling
- (2013) J N Kyula et al. ONCOGENE
- The incidences and mortalities of major cancers in China, 2009
- (2013) Wanqing Chen et al. Chinese Journal of Cancer
- Radiovirotherapy: Principles and Prospects in Oncology
- (2012) Y. Touchefeu et al. CURRENT PHARMACEUTICAL DESIGN
- Conserved Fiber-Penton Base Interaction Revealed by Nearly Atomic Resolution Cryo-Electron Microscopy of the Structure of Adenovirus Provides Insight into Receptor Interaction
- (2012) C. Cao et al. JOURNAL OF VIROLOGY
- Genome Sequence of Herpes Simplex Virus 1 Strain KOS
- (2012) S. J. Macdonald et al. JOURNAL OF VIROLOGY
- Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression
- (2012) Omar D Perez et al. MOLECULAR THERAPY
- Crosstalk Between Immune Cell and Oncolytic Vaccinia Therapy Enhances Tumor Trafficking and Antitumor Effects
- (2012) Padma Sampath et al. MOLECULAR THERAPY
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Adenovirus receptors: implications for targeting of viral vectors
- (2012) Niklas Arnberg TRENDS IN PHARMACOLOGICAL SCIENCES
- Theranostic Potential of Oncolytic Vaccinia Virus
- (2012) Juan J Rojas et al. Theranostics
- Immune Recruitment and Therapeutic Synergy: Keys to Optimizing Oncolytic Viral Therapy?
- (2011) J. D. Naik et al. CLINICAL CANCER RESEARCH
- Oncolytic vaccinia virus for the treatment of cancer
- (2011) Kilian Guse et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Feasibility of Adenovirus-Mediated hNIS Gene Transfer and 131I Radioiodine Therapy as a Definitive Treatment for Localized Prostate Cancer
- (2011) Kenneth N Barton et al. MOLECULAR THERAPY
- Sequential Therapy With JX-594, A Targeted Oncolytic Poxvirus, Followed by Sorafenib in Hepatocellular Carcinoma: Preclinical and Clinical Demonstration of Combination Efficacy
- (2011) Jeong Heo et al. MOLECULAR THERAPY
- Oncolytic Adenoviruses Armed with Thymidine Kinase Can Be Traced by PET Imaging and Show Potent Antitumoural Effects by Ganciclovir Dosing
- (2011) Daniel Abate-Daga et al. PLoS One
- Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity
- (2011) R. Dash et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Induction and function of virus-specific CD4+ T cell responses
- (2011) Jason K. Whitmire VIROLOGY
- Synergistic action of oncolytic herpes simplex virus and radiotherapy in pancreatic cancer cell lines
- (2010) M.-H. Dai et al. BRITISH JOURNAL OF SURGERY
- Type B coxsackieviruses and their interactions with the innate and adaptive immune systems
- (2010) Christopher C Kemball et al. Future Microbiology
- Synergistic anti-tumor effects between oncolytic vaccinia virus and paclitaxel are mediated by the IFN response and HMGB1
- (2010) B Huang et al. GENE THERAPY
- Phase I/II Study of Oncolytic Herpes Simplex Virus NV1020 in Patients with Extensively Pretreated Refractory Colorectal Cancer Metastatic to the Liver
- (2010) Sunil K. Geevarghese et al. HUMAN GENE THERAPY
- Bystander killing of cancer requires the cooperation of CD4+and CD8+T cells during the effector phase
- (2010) Andrea Schietinger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
- (2009) Howard L. Kaufman et al. ANNALS OF SURGICAL ONCOLOGY
- Replacement of Adenovirus Type 5 Fiber Shaft Heparan Sulfate Proteoglycan-Binding Domain with RGD for Improved Tumor Infectivity and Targeting
- (2009) Neus Bayo-Puxan et al. HUMAN GENE THERAPY
- The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of Solomon
- (2009) Robin J. Prestwich et al. HUMAN GENE THERAPY
- A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors
- (2009) John Nemunaitis et al. MOLECULAR THERAPY
- Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity
- (2008) R. J. Prestwich et al. CLINICAL CANCER RESEARCH
- Phase I Study of Noninvasive Imaging of Adenovirus-mediated Gene Expression in the Human Prostate
- (2008) Kenneth N Barton et al. MOLECULAR THERAPY
- Oncolytic herpes virus with defective ICP6 specifically replicates in quiescent cells with homozygous genetic mutations in p16
- (2008) M Aghi et al. ONCOGENE
- Bacterial targeted tumour therapy-dawn of a new era
- (2007) Ming Q Wei et al. CANCER LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search